Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes
Abstract Background The National Institutes of Health Office of Medical Applications of
Research commissioned a structured literature review on the incidence, treatment, and …
Research commissioned a structured literature review on the incidence, treatment, and …
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis
While ductal carcinoma in situ (DCIS) is seldom life threatening, the management of DCIS
remains a dilemma for patients and their physicians. Aggressive treatment reduces the risk …
remains a dilemma for patients and their physicians. Aggressive treatment reduces the risk …
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
Background Ipsilateral breast tumor recurrence (IBTR) is the most common failure event
after lumpectomy for ductal carcinoma in situ (DCIS). We evaluated invasive IBTR (I-IBTR) …
after lumpectomy for ductal carcinoma in situ (DCIS). We evaluated invasive IBTR (I-IBTR) …
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography
D Saslow, C Boetes, W Burke, S Harms… - CA: a cancer journal …, 2007 - Wiley Online Library
New evidence on breast Magnetic Resonance Imaging (MRI) screening has become
available since the American Cancer Society (ACS) last issued guidelines for the early …
available since the American Cancer Society (ACS) last issued guidelines for the early …
Cancer statistics: breast cancer in situ
An estimated 60,290 new cases of breast carcinoma in situ are expected to be diagnosed in
2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer …
2015, and approximately 1 in 33 women is likely to receive an in situ breast cancer …
[KSIĄŻKA][B] The breast: comprehensive management of benign and malignant diseases
KI Bland, EM Copeland, VS Klimberg, WJ Gradishar - 2023 - books.google.com
Multidisciplinary in scope and fully up to date with the latest advances in medical oncology
and more, Bland and Copeland's The Breast, 6th Edition, covers every clinically relevant …
and more, Bland and Copeland's The Breast, 6th Edition, covers every clinically relevant …
Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ
Background: Collagen fibers surrounding breast ducts may influence breast cancer
progression. Syndecan-1 interacts with constituents in the extracellular matrix, including …
progression. Syndecan-1 interacts with constituents in the extracellular matrix, including …
The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004
CR Eheman, KM Shaw, AB Ryerson, JW Miller… - … Biomarkers & Prevention, 2009 - AACR
Background: National incidence rates for lobular and ductal breast cancers have not been
available previously. Evidence suggests that the increased risk of breast cancer associated …
available previously. Evidence suggests that the increased risk of breast cancer associated …
[KSIĄŻKA][B] Preventive strikes: women, precancer, and prophylactic surgery
I Löwy - 2010 - books.google.com
Winner, 2011 Best Book in the History of Medicine, European Association for the History of
Medicine and Health Modern scientific tools can identify a genetic predisposition to cancer …
Medicine and Health Modern scientific tools can identify a genetic predisposition to cancer …
Lobular breast carcinoma and its variants
EA Rakha, IO Ellis - Seminars in diagnostic pathology, 2010 - Elsevier
Lobular carcinoma is a special type of breast cancer that shows distinct clinical presentation,
morphologic and molecular features, and clinical behavior, and its incidence is rising in …
morphologic and molecular features, and clinical behavior, and its incidence is rising in …